![](/img/cover-not-exists.png)
Repurposing CD8 + T cell immunity against SARS-CoV-2 for cancer immunotherapy: a positive aspect of the COVID-19 pandemic?
Gujar, Shashi, Pol, Jonathan G., Kim, Youra, Kroemer, GuidoVolume:
9
Journal:
OncoImmunology
DOI:
10.1080/2162402X.2020.1794424
Date:
January, 2020
File:
PDF, 1.34 MB
2020